Insulin Delivery Devices Market By Product (Insulin syringes, Insulin pens, Insulin pumps, Insulin injectors) By End Use (Hospitals, Homecare, Others)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Key Highlights of the Report

The global insulin delivery devices market is segmented by product, end-use, and region. Insulin pens product segment is the most popular, while insulin syringes and insulin pumps are the two primary product segments. Homecare is the end use, with Europe leading the market growth.

The global insulin delivery devices market has several drivers, including the rising prevalence of diabetes globally & growing emphasis on patient-centric care. Additionally, government initiatives and reimbursement policies significantly impact the adoption and accessibility of insulin-delivery devices. However, the market also faces significant challenges, including high costs hindering access to insulin delivery devices & limited access to insulin delivery devices in underserved areas.

Nonetheless, the global insulin delivery devices market offers significant growth opportunities, including development of advanced diagnostic technologies in the European region. Moreover, strengthening pharmacovigilance systems and enhancing adverse event monitoring can significantly benefit the global insulin delivery devices industry.

Market Overview

The global Insulin delivery devices market has witnessed steady growth in recent years and is expected to continue growing at a CAGR of 7.80% between 2023 and 2030. The market was valued at USD 13.8 billion in 2022 and is expected to reach USD 23.34588879 billion in 2030.

What Are the Main Drivers Of The Global Insulin delivery devices Market?

The global Insulin delivery devices market is driven by several factors, including the rising prevalence of diabetes globally & growing emphasis on patient-centric care.

What Are the Major Challenges Faced by The Global Insulin delivery devices Market?

The global Insulin delivery devices market also faces several challenges, including high costs hindering access to insulin delivery devices & limited access to insulin delivery devices in underserved areas.

What Are the Growth Opportunities in The Global Insulin delivery devices Market?

The global Insulin delivery devices market offers significant growth opportunities, including the integration of advanced technologies such as artificial intelligence (AI), machine learning, and Internet of Things (IoT) & emergence of wearable devices and CGM systems.

Executive Summary

Overview of the Global Insulin delivery devices Market

The global Insulin delivery devices market has been steadily growing in recent years due to the surging number of diabetics due to aging, obesity, and unhealthy lifestyles. Obesity is believed to be a major factor leading to the development of diabetes in individuals. According to the WHO, in 2014, over 1.9 billion people were identified to be overweight, of which around 600 million people were obese. The market is characterized by a wide range of equipment, designs, and sizes, catering to diverse consumer preferences.

Market Definition

The market for insulin delivery devices is the area of the healthcare sector that is dedicated to the development, marketing, and use of equipment used to deliver insulin to diabetics. These tools include insulin pens, insulin pumps, insulin syringes, and other cutting-edge delivery systems. The market includes producers, healthcare practitioners, and people with diabetes who depend on these devices to manage their disease. By offering simple and effective ways to administer insulin, boosting treatment adherence, and maximising diabetes management, the market for insulin delivery devices is crucial to improving patient outcomes.

Market Insights

• The global demand for Insulin delivery devices was valued at USD 13.8 Billion in 2022 and is expected to reach USD 23.34588879 Billion in 2030, growing at a CAGR of 7.80% between 2023 and 2030.
• Insulin pens product is the leading segment and held around half of share in terms of value in 2022, while the insulin syringes segment is likely to exhibit the fastest CAGR during the forecast period.
• Homecare is expected to post the highest CAGR during the forecast period & leading the market share with more than 25% share in 2022.
• Europe is fueling the growth of the Insulin delivery devices industry with nearly two-fifth share in 2022, while North America and Asia-pacific collectively account for just nearly under 55% share in 2022. Asia-pacific held over 22% share in 2022.
• The rising prevalence of diabetes globally & growing emphasis on patient-centric care are the major drivers of the market. At the same time, socioeconomic disparities and, uneven access to healthcare services & affordability challenges in low and middle-income countries are the main restraints.
• The integration of advanced technologies such as artificial intelligence (AI), machine learning, and Internet of Things (IoT) & emergence of wearable devices and CGM systems as the major opportunities in the market.

Segmentation by Product

• Insulin pens product type is the leading segment and held around half a share in value in 2022.
• The insulin syringes and insulin pumps will likely exhibit the fastest CAGR during the forecast period.

Segmentation by End Use

• The Homecare segment governs the demand for insulin delivery devices in the world, holding a massive share, and is also expected to grow at a rapid CAGR.
• The Hospitals segment contributes the rest to the demand for Insulin delivery devices.

Segmentation by Region

• Europe was fueling the growth of the Insulin delivery devices industry with a nearly two-fifths share in 2022.
• North America and Asia-pacific collectively account for nearly under 55% share in 2022, with Asia-pacific holding over 22% share in the same year.
• The rest of the world, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for Insulin delivery devices.

The increasing demand for insulin delivery devices can be attributed to the surging number of diabetics due to aging, obesity, and unhealthy lifestyles. Obesity is believed to be a major factor leading to the development of diabetes in individuals. However, the market is restrained by the socioeconomic disparities and uneven access to healthcare services & affordability challenges in low and middle-income countries.

France is known for having significant capacities for research and development, particularly in the field of healthcare. It has a strong ecosystem of research organisations, educational institutions, and healthcare facilities that promote medical device innovation, including the development of insulin delivery systems. This focus on R&D encourages the creation of innovative products and technology, allowing French businesses to remain competitive in the market. Additionally, it is the location of numerous prominent manufacturers and medical technology firms that are devoted to the creation of insulin-delivery devices. These businesses frequently have cutting-edge technological know-how, which allows them to create unique, high-quality products.

The US has a strong medical device regulatory framework that guarantees high standards of safety and quality as well as a well-established and comprehensive healthcare system. Consumers and healthcare professionals can feel confident in the security and effectiveness of insulin delivery devices because to the strict approval process. This regulatory framework encourages businesses to spend in R&D and compliance, giving US manufacturers a competitive edge.

Overall, the increasing demand for insulin delivery devices can be attributed to the rising prevalence of diabetes globally & growing emphasis on patient-centric care.

While the insulin delivery devices market is growing, it faces challenges such as high costs hindering access to insulin delivery devices & limited access to insulin delivery devices in underserved areas.

Increasing Prevalence of Diabetes

The demand for insulin delivery devices is greatly influenced by the rising prevalence of diabetes worldwide. There is a significant need for efficient insulin administration techniques due to the rise in diabetes diagnoses, including both type 1 and type 2 diabetes. In order to help people manage their disease, there is a growing need for effective and creative equipment.

The number of people with diabetes worldwide has been gradually increasing over time. The International Diabetes Federation estimates that 463 million persons worldwide had diabetes in 2019; by 2045, this figure is expected to rise to 700 million. In order to better control their disease, the increasing number of persons with diabetes who have been diagnosed generates a significant need for insulin administration devices.

Technological Advancements

The field of insulin delivery devices has undergone a revolution because to technological advancements. The design, functionality, and features of these products are always being improved by businesses through research and development. This includes technological advancements like intelligent insulin pens, integrated continuous glucose monitoring (CGM) systems, and communication options with smartphones and other gadgets. Accuracy, convenience, and usability are all improved by technological developments, which also improve patient experiences and outcomes.

Additionally, modern technology is used into smart insulin pens to improve ease of use and precision of insulin administration. The majority of these pens have digital displays, dose remembering capabilities, and integrated dose calculators. They assist patients in keeping track of their insulin dosages, keep track of past injections, and send out reminders for scheduled doses. Smart pens make managing insulin easier, lower the chance of mistakes, and improve treatment plan adherence.

Economic and Healthcare Disparities

The mass use of insulin delivery devices may face difficulties due to socioeconomic inequalities and unequal access to healthcare services. The pricing, availability, and accessibility of these devices may be hampered by scarce financial resources and inadequate healthcare infrastructure in some areas. For all diabetics to have equitable access to insulin delivery devices, it is essential to address the economic and healthcare inequalities that exist.

The management of diabetes may not be as effective for those with unequal access to insulin delivery systems, which can have a negative impact on their health. Healthcare professionals can enable people to better regulate their blood glucose levels, lowering the risk of problems and improving their overall health outcomes, by eliminating inequities and granting equal access to these devices        .

Wearable Devices and Continuous Glucose Monitoring (CGM)

The development of wearable technology and CGM systems presents new market prospects for insulin delivery systems. These devices provide real-time glucose measurements and automate insulin administration, easing the load of laborious calculations and improving treatment precision. They also combine the capability of insulin delivery with continuous glucose monitoring. Due to the prompt modifications that may be made to insulin therapy thanks to this integration, glycaemic control is improved, and the risk of hypo- or hyperglycemia is decreased.

Competitive Landscape

Key Players

The global Insulin delivery devices market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

• Novo Nordisk A/S
• Sanofi
• Eli Lilly and Company
• Biocon Ltd
• Ypsomed AG
• Wockhardt Ltd.
• Medtronic
• Abbott Laboratories
• F. Hoffmann-La Roche, Ltd.

These companies focus on product innovation, expanding their applications, mergers, and acquisitions to stay ahead in the market. The major players in the global Insulin delivery devices market are constantly striving to stay ahead by introducing new products and innovations.

In 2022, Novo Nordisk launched smart insulin in the UK. This novel product launch offers a competitive advantage and strengthens its industrial position in the UK region.

In 2020, Medtronic launched the InPen smart insulin pen that is integrated with real-time Guardian Connect CGM data, which offers real-time glucose readings coupled with insulin dose data and makes it easier to make smarter dosing decisions. This product launch assisted the company in driving the sales & revenue generation in insulin delivery devices market.

Summary of Key Findings

• The rising prevalence of diabetes globally & growing emphasis on patient-centric care driving market growth
• Market segmented by product, end use, and region.
• Insulin pens product is the most popular, with insulin syringes and insulin pumps as primary product segments.
• Homecare is the most common end-use segment.
• Europe is leading market growth; the market is highly competitive with key players including Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Biocon Ltd., Ypsomed AG and others.

Future Outlook

• Positive outlook for the global insulin delivery devices market with significant growth potential in the Europe region
• The rising prevalence of diabetes globally & growing emphasis on patient-centric care drive growth
• Challenges high costs hindering access to insulin delivery devices & limited access to insulin delivery devices in underserved areas.

Segmentation

• By Product
  • Insulin syringes
  • Insulin pens
  • Insulin pumps
  • Insulin injectors
• By End Use
  • Hospitals
  • Homecare
  • Others
• By Region

• North America
  • The US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • The U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Insulin Delivery Devices Market
2.2. Global Insulin Delivery Devices Market, By Product
2.3. Global Insulin Delivery Devices Market, By End Use
2.4. Global Insulin Delivery Devices Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Insulin Delivery Devices Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.2.4. Major Industry Challenges
3.2.4.1. Challenge 1
3.2.4.2. Challenge 2
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Product
3.5.2. End Use
3.5.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Insulin Delivery Devices Market, By Product
7.1. Global Insulin Delivery Devices Market Overview, by Product
7.1.1. Global Insulin Delivery Devices Market Revenue Share, By Product, 2022 Vs 2030 (in %)
7.2. Insulin syringes
7.2.1. Global Insulin Delivery Devices Market, By Region, 2017-2030 (US$ Bn)
7.3. Insulin pens
7.3.1. Global Insulin Delivery Devices Market, By Region, 2017-2030 (US$ Bn)
7.4. Insulin pumps
7.4.1. Global Insulin Delivery Devices Market, By Region, 2017-2030 (US$ Bn)
7.5. Insulin injectors
7.5.1. Global Insulin Delivery Devices Market, By Region, 2017-2030 (US$ Bn)

8. Global Insulin Delivery Devices Market, By End Use
8.1. Global Insulin Delivery Devices Market Overview, by End Use
8.1.1. Global Insulin Delivery Devices Market, By End Use, 2022 vs 2030 (in %)
8.2. Homecare
8.2.1. Global Insulin Delivery Devices Market, By Region, 2017-2030 (US$ Bn)
8.3. Hospitals
8.3.1. Global Insulin Delivery Devices Market, By Region, 2017-2030 (US$ Bn)
8.4. Others
8.4.1. Global Insulin Delivery Devices Market, By Region, 2017-2030 (US$ Bn)

9. Global Insulin Delivery Devices Market, By Region
9.1. Global Insulin Delivery Devices Market Overview, by Region
9.1.1. Global Insulin Delivery Devices Market, By Region, 2022 vs 2030 (in%)
9.2. Product
9.2.1. Global Insulin Delivery Devices Market, By Product, 2017-2030 (US$ Bn)
9.3. End Use
9.3.1. Global Insulin Delivery Devices Market, By End Use, 2017-2030 (US$ Bn)

10. North America Insulin Delivery Devices Market Analysis
10.1. North America Insulin Delivery Devices Market, by Product, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. North America Insulin Delivery Devices Market, by End Use, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. North America Insulin Delivery Devices Market, by Country, 2017-2030 (US$ Bn)
10.3.1. North America Insulin Delivery Devices Market, by Country, 2022 Vs 2030 (in%)
10.3.2. U.S.
10.3.2.1. U.S. Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.2.2. U.S. Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
10.3.2.3. U.S. Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
10.3.3. Canada
10.3.3.1. Canada Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.3.2. Canada Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
10.3.3.3. Canada Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
10.3.4. Mexico
10.3.4.1. Mexico Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.4.2. Mexico Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
10.3.4.3. Mexico Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)

11. Europe Insulin Delivery Devices Market Analysis
11.1. Europe Insulin Delivery Devices Market, by Product, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Europe Insulin Delivery Devices Market, by End Use, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Europe Insulin Delivery Devices Market, by Country, 2017-2030 (US$ Bn)
11.3.1. Europe Insulin Delivery Devices Market, by Country, 2022 Vs 2030 (in%)
11.3.2. Germany
11.3.2.1. Germany Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.2.2. Germany Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
11.3.2.3. Germany Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
11.3.3. France
11.3.3.1. France Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.3.2. France Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
11.3.3.3. France Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
11.3.4. UK
11.3.4.1. UK Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.4.2. UK Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
11.3.4.3. UK Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
11.3.5. Italy
11.3.5.1. Italy Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.5.2. Italy Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
11.3.5.3. Italy Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
11.3.6. Spain
11.3.6.1. Spain Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.6.2. Spain Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
11.3.6.3. Spain Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
11.3.7. Rest of Europe
11.3.7.1. Rest of Europe Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.7.2. Rest of Europe Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
11.3.7.3. Rest of Europe Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)

12. Asia Pacific Insulin Delivery Devices Market Analysis
12.1. Asia Pacific Insulin Delivery Devices Market, by Product, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Asia Pacific Insulin Delivery Devices Market, by End Use, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Asia Pacific Insulin Delivery Devices Market, by Country, 2017-2030 (US$ Bn)
12.3.1. Asia Pacific Insulin Delivery Devices Market, by Country, 2022 Vs 2030 (in%)
12.3.2. China
12.3.2.1. China Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.2.2. China Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
12.3.2.3. China Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
12.3.3. Japan
12.3.3.1. Japan Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.3.2. Japan Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
12.3.3.3. Japan Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
12.3.4. India
12.3.4.1. India Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.4.2. India Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
12.3.4.3. India Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
12.3.5. South Korea
12.3.5.1. South Korea Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.5.2. South Korea Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
12.3.5.3. South Korea Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
12.3.6. South-East Asia
12.3.6.1. South-East Asia Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.6.2. South-East Asia Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
12.3.6.3. South-East Asia Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
12.3.7. Rest of Asia Pacific
12.3.7.1. Rest of Asia Pacific Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.7.2. Rest of Asia Pacific Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
12.3.7.3. Rest of Asia Pacific Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)

13. Latin America Insulin Delivery Devices Market Analysis
13.1. Latin America Insulin Delivery Devices Market, by Product, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Latin America Insulin Delivery Devices Market, by End Use, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Latin America Insulin Delivery Devices Market, by Country, 2017-2030 (US$ Bn)
13.3.1. Latin America Insulin Delivery Devices Market, by Country, 2022 Vs 2030 (in%)
13.3.2. Brazil
13.3.2.1. Brazil Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.2.2. Brazil Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
13.3.2.3. Brazil Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
13.3.3. Argentina
13.3.3.1. Argentina Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.3.2. Argentina Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
13.3.3.3. Argentina Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
13.3.4. Rest of Latin America
13.3.4.1. Rest of Latin America Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.4.2. Rest of Latin America Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
13.3.4.3. Rest of Latin America Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)

14. Middle East and Africa Insulin Delivery Devices Market Analysis
14.1. Middle East and Africa Insulin Delivery Devices Market, by Product, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Middle East and Africa Insulin Delivery Devices Market, by End Use, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Middle East and Africa Insulin Delivery Devices Market, by Country, 2017-2030 (US$ Bn)
14.3.1. Middle East and Africa Insulin Delivery Devices Market, by Country, 2022 Vs 2030 (in%)
14.3.2. GCC Countries
14.3.2.1. GCC Countries Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.2.2. GCC Countries Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
14.3.2.3. GCC Countries Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
14.3.3. South Africa
14.3.3.1. South Africa Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.3.2. South Africa Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
14.3.3.3. South Africa Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)
14.3.4. Rest of Middle East and Africa
14.3.4.1. Rest of Middle East and Africa Insulin Delivery Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.4.2. Rest of Middle East and Africa Insulin Delivery Devices, By Product, 2017-2030 (US$ Bn)
14.3.4.3. Rest of Middle East and Africa Insulin Delivery Devices, By End Use, 2017-2030 (US$ Bn)

15. Company Profiles
15.1. Novo Nordisk A/S
15.1.1. Company Overview
15.1.2. Products/Services Portfolio
15.1.3. Geographical Presence
15.1.4. Financial Summary
15.1.4.1. Market Revenue and Net Profit (2019-2022)
15.1.4.2. Business Segment Revenue Analysis
15.1.4.3. Geographical Revenue Analysis
15.2. Sanofi
15.3. Eli Lilly and Company
15.4. Biocon Ltd.
15.5. Ypsomed AG
15.6. Wockhardt Ltd.
15.7. Medtronic
15.8. Abbott Laboratories
15.9. F. Hoffmann-La Roche, Ltd

List of Figures
FIG. 1 Global Insulin Delivery Devices Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Insulin Delivery Devices Market Segmentation
FIG. 4 Global Insulin Delivery Devices Market, by Product, 2022 (US$ Bn)
FIG. 5 Global Insulin Delivery Devices Market, by End Use, 2022 (US$ Bn)
FIG. 6 Global Insulin Delivery Devices Market, by Geography, 2022 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Product, 2022
FIG. 8 Attractive Investment Proposition, by End Use, 2022
FIG. 9 Attractive Investment Proposition, by Geography, 2022
FIG. 10 Global Market Share Analysis of Key Insulin Delivery Devices Market Manufacturers, 2022
FIG. 11 Global Market Positioning of Key Insulin Delivery Devices Market Manufacturers, 2022
FIG. 12 Global Insulin Delivery Devices Market Value Contribution, By Product, 2022 & 2030 (Value %)
FIG. 13 Global Insulin Delivery Devices Market, by Insulin syringes, Value, 2017-2030 (US$ Bn)
FIG. 14 Global Insulin Delivery Devices Market, by Insulin pens, Value, 2017-2030 (US$ Bn)
FIG. 15 Global Insulin Delivery Devices Market, by Insulin pumps, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Insulin Delivery Devices Market, by Insulin injectors, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Insulin Delivery Devices Market Value Contribution, By End Use, 2022 & 2030 (Value %)
FIG. 18 Global Insulin Delivery Devices Market, by Homecare, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Insulin Delivery Devices Market, by Hospitals, 2017-2030 (US$ Bn)
FIG. 20 Global Insulin Delivery Devices Market, by Others, 2017-2030 (US$ Bn)
FIG. 21 North America Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 22 U.S. Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 23 Canada Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 24 Europe Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 25 Germany Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 26 France Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 27 U.K. Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 28 Italy Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 29 Spain Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 30 Rest of Europe Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 31 Asia Pacific Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 32 China Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 33 Japan Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 34 India Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 35 South Korea Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 36 South-East Asia Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 37 Rest of Asia Pacific Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 38 Latin America Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 39 Brazil Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 40 Mexico Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 41 Rest of Latin America Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 42 Middle East & Africa Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 43 GCC Countries Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 44 South Africa Insulin Delivery Devices Market, 2017-2030 (US$ Bn)
FIG. 45 Rest of Middle East and Africa Insulin Delivery Devices Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Insulin Delivery Devices Market
TABLE 2 Global Insulin Delivery Devices Market: Market Drivers Impact Analysis
TABLE 3 Global Insulin Delivery Devices Market: Market Restraints Impact Analysis
TABLE 4 Global Insulin Delivery Devices Market, by Competitive Benchmarking, 2022
TABLE 5 Global Insulin Delivery Devices Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Insulin Delivery Devices Market, by Key Strategies Analysis, 2022
TABLE 7 Global Insulin Delivery Devices Market, by Insulin syringes, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Insulin Delivery Devices Market, by Insulin syringes, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Insulin Delivery Devices Market, by Insulin pens, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Insulin Delivery Devices Market, by Insulin pens, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Insulin Delivery Devices Market, by Insulin pumps, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Insulin Delivery Devices Market, by Insulin pumps, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Insulin Delivery Devices Market, by Insulin injectors, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Insulin Delivery Devices Market, by Insulin injectors, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Insulin Delivery Devices Market, by Homecare, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Insulin Delivery Devices Market, by Homecare, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Insulin Delivery Devices Market, by Hospitals, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Insulin Delivery Devices Market, by Hospitals, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Insulin Delivery Devices Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Insulin Delivery Devices Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 22 Global Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 23 Global Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 24 Global Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 25 Global Insulin Delivery Devices Market, by Region, 2017-2022 (US$ Bn)
TABLE 26 Global Insulin Delivery Devices Market, by Region, 2023-2030 (US$ Bn)
TABLE 27 North America Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 28 North America Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 29 North America Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 30 North America Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 31 North America Insulin Delivery Devices Market, by Country, 2017-2022 (US$ Bn)
TABLE 32 North America Insulin Delivery Devices Market, by Country, 2023-2030 (US$ Bn)
TABLE 33 United States Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 34 United States Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 35 United States Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 36 United States Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 37 Canada Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 38 Canada Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 39 Canada Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 40 Canada Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 41 Mexico Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 42 Mexico Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 43 Mexico Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 44 Mexico Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 45 Europe Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 46 Europe Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 47 Europe Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 48 Europe Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 49 Europe Insulin Delivery Devices Market, by Country, 2017-2022 (US$ Bn)
TABLE 50 Europe Insulin Delivery Devices Market, by Country, 2023-2030 (US$ Bn)
TABLE 51 Germany Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 52 Germany Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 53 Germany Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 54 Germany Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 55 France Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 56 France Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 57 France Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 58 France Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 59 United Kingdom Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 60 United Kingdom Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 61 United Kingdom Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 62 United Kingdom Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 63 Italy Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 64 Italy Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 65 Italy Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 66 Italy Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 67 Spain Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 68 Spain Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 69 Spain Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 70 Spain Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 71 Rest of Europe Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 72 Rest of Europe Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 73 Rest of Europe Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 74 Rest of Europe Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 75 Asia Pacific Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 76 Asia Pacific Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 77 Asia Pacific Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 78 Asia Pacific Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 79 Asia Pacific Insulin Delivery Devices Market, by Country, 2017-2022 (US$ Bn)
TABLE 80 Asia Pacific Insulin Delivery Devices Market, by Country, 2023-2030 (US$ Bn)
TABLE 81 China Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 82 China Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 83 China Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 84 China Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 85 Japan Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 86 Japan Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 87 Japan Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 88 Japan Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 89 India Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 90 India Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 91 India Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 92 India Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 93 South Korea Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 94 South Korea Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 95 South Korea Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 96 South Korea Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 97 South-East Asia Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 98 South-East Asia Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 99 South-East Asia Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 100 South-East Asia Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 101 Rest of Asia Pacific Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 102 Rest of Asia Pacific Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 103 Rest of Asia Pacific Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 104 Rest of Asia Pacific Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 105 Latin America Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 106 Latin America Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 107 Latin America Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 108 Latin America Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 109 Latin America Insulin Delivery Devices Market, by Country, 2017-2022 (US$ Bn)
TABLE 110 Latin America Insulin Delivery Devices Market, by Country, 2023-2030 (US$ Bn)
TABLE 111 Brazil Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 112 Brazil Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 113 Brazil Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 114 Brazil Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 115 Argentina Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 116 Argentina Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 117 Argentina Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 118 Argentina Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 119 Rest of Latin America Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 120 Rest of Latin America Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 121 Rest of Latin America Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 122 Rest of Latin America Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 123 Middle East and Africa Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 124 Middle East and Africa Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 125 Middle East and Africa Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 126 Middle East and Africa Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 127 Middle East and Africa Insulin Delivery Devices Market, by Country, 2017-2022 (US$ Bn)
TABLE 128 Middle East and Africa Insulin Delivery Devices Market, by Country, 2023-2030 (US$ Bn)
TABLE 129 GCC Countries Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 130 GCC Countries Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 131 GCC Countries Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 132 GCC Countries Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 133 South Africa Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 134 South Africa Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 135 South Africa Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 136 South Africa Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)
TABLE 137 Rest of Middle East and Africa Insulin Delivery Devices Market, by Product, 2017-2022 (US$ Bn)
TABLE 138 Rest of Middle East and Africa Insulin Delivery Devices Market, by Product, 2023-2030 (US$ Bn)
TABLE 139 Rest of Middle East and Africa Insulin Delivery Devices Market, by End Use, 2017-2022 (US$ Bn)
TABLE 140 Rest of Middle East and Africa Insulin Delivery Devices Market, by End Use, 2023-2030 (US$ Bn)